Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.74 |
| ▸ | HPGD | P15428 | 1/20 | 0.74 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.74 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.74 |
| ▸ | CASP1 | P29466 | 1/20 | 0.74 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.74 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.54 |
| ▸ | MAOA | P21397 | 1/20 | 0.54 |
| ▸ | MAOB | P27338 | 2/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.52 |
| ▸ | IDO1 | P14902 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7544128 | 0.97 | ALDH1A1 (0.70) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| SCHEMBL445067 | 0.92 | ALDH1A1 (0.70) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| SCHEMBL3625544 | 0.90 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| SCHEMBL6683681 | 0.90 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| Hydrochloric Acid SCHEMBL28408129 | 0.90 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| SCHEMBL6379725 | 0.90 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| SCHEMBL2112457 | 0.90 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| SCHEMBL8500856 | 0.90 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| SCHEMBL282602 | 0.90 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 | |
| SCHEMBL6680538 | 0.90 | ALDH1A1 (0.67) | ALDH1A1HPGDALOX15ALOX12CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 349 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12509426-B1 | Carbon-14 radioisotope-labeled flonicamid and synthesis method thereof | Zhejiang Isotope Labelled Compounds Co., Ltd (CN) | 2025-12-30 | — | — | US | claimed |
| CN-119285540-B | Radioisotope carbon-14 labeled flonicamid and synthesis method thereof | 浙江爱索拓标记医药科技有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-119285540-A | Radioisotope carbon-14 labeled flonicamid and synthesis method thereof | 浙江爱索拓标记医药科技有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-116406213-A | Chemical method for inhibiting ion diffusion in perovskite battery | 华东理工大学 | 2023-07-07 | — | — | CN | claimed |
| CN-1279022-C | Sulfonated alkyl aromatic diamine and its hydrochloride and method for preparing same | UNIV SHANGHAI JIAOTONG (CN) | 2006-10-11 | — | — | CN | claimed |
| CN-1634880-A | Sulfonated alkyl aromatic diamine and its hydrochloride and method for preparing same | UNIV SHANGHAI JIAOTONG (CN) | 2005-07-06 | — | — | CN | claimed |
| EP-4747260-A1 | MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE | F. Hoffmann-La Roche AG (CH) | 2026-05-27 | — | — | EP | disclosed |
| US-20260070927-A1 | INDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE | HOFFMANN-LA ROCHE INC. (US) | 2026-03-12 | — | — | US | disclosed |
| US-12509426-B1 | Carbon-14 radioisotope-labeled flonicamid and synthesis method thereof | Zhejiang Isotope Labelled Compounds Co., Ltd (CN) | 2025-12-30 | — | — | US | disclosed |
| US-20250188078-A1 | SMALL MOLECULE INHIBITORS OF THE CRL4 UBIQUITIN LIGASE | CORNELL UNIVERSITY (US) | 2025-06-12 | — | — | US | disclosed |
| EP-4536662-A1 | INDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE | F. Hoffmann-La Roche AG (CH) | 2025-04-16 | — | — | EP | disclosed |
| CN-119285540-B | Radioisotope carbon-14 labeled flonicamid and synthesis method thereof | 浙江爱索拓标记医药科技有限公司 | 2025-04-04 | — | — | CN | disclosed |
| WO-2025021666-A1 | MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE | F. HOFFMANN-LA ROCHE AG (CH) | 2025-01-30 | — | — | WO | disclosed |
| CN-1049347-A | Novel 1-oxa--2-oxo-8-azaspiro [4,5] decane derivative, the method that contains the pharmaceutical composition of this analog derivative and prepare them | RICHTER GEDEON VEGYESZET (HU) | 1991-02-20 | — | — | CN | disclosed |
| EP-0015776-B1 | 1,1'-BIPHENYL-2-YL ALKYLAMINE DERIVATIVES, THEIR PRODUCTION AND CARDIOVASCULAR PREPARATIONS CONTAINING SAME | ELI LILLY AND COMPANY (US) | 1982-06-30 | — | — | EP | disclosed |
| US-4277471-A | 1,1-Biphenyl-2-yl alkylamines, formulations and antiarrhythmic treatment | ELI LILLY AND COMPANY (US) | 1981-07-07 | — | — | US | disclosed |
| EP-0015776-A1 | 1,1'-Biphenyl-2-yl alkylamine derivatives, their production and cardiovascular preparations containing same | ELI LILLY AND COMPANY (US) | 1980-09-17 | — | — | EP | disclosed |
| US-4198429-A | BRONCHOSPASMOLYTIC | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-04-15 | — | — | US | disclosed |
| US-4087426-A | Oxybisberberine and a process for its production | RESEARCH CORPORATION (US) | 1978-05-02 | — | — | US | disclosed |
| US-3956237-A | HINDERED UREA OR THIOUREA | THE DOW CHEMICAL COMPANY (US) | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509426-B1 | Carbon-14 radioisotope-labeled flonicamid and synthesis method thereof | TMEM14C, RPL14, FOS | ALDH1A1 2800/4885HPGD 4520/4885ALOX15 3444/4885 |
| US-20250188078-A1 | SMALL MOLECULE INHIBITORS OF THE CRL4 UBIQUITIN LIGASE | DDB1, CUL4A, CUL4B | ALDH1A1 2081/4885HPGD 3160/4885ALOX15 4237/4885 |
| US-20260070927-A1 | INDAZOLE MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE | MALT1, CCR1, CCR6 | ALDH1A1 335/4885HPGD 4335/4885ALOX15 2178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.